Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Granulomatosis of Wegener’s

Wolfgang L. Gross, MD, PhD, Antje Mueller, PhD, and Julia Holle, MD  |  Issue: May 2011  |  May 16, 2011

PMN, aggregating to neutrophilic microabscesses (see the left panel of Figure 2, p. 41)—frequently in the center of epitheloid cell granulomas—undergo cell death, eventually forming areas of geographic necrosis.20 This cell death may occur via NETosis, a cell death program that could play a central role in the induction of autoimmunity.22

Within the inflammatory lesions of granulomatous WG, lymphocytes together with follicular dendritic cells form germinal center-like structures (see the right panel of Figure 2, p. 41), a process very similar to rheumatoid synovium. These follicular structures provide a microenvironment for the development of autoreactive B cells (see below), which may link both hallmarks of WG, the granulomatous lesion as a site of autoantibody production and the autoimmune vasculitis. Surprisingly, another pathogenic process takes place in the granulomatous lesion (i.e., cartilage) (see the right panel of Figure 1, p. 41) and bone destruction (see the right panel of Figure 2, p. 41). This process has marked similarity to events in the rheumatoid synovium.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Autoantigens and Autoantibodies in the Granulomatous Lesion

Autoantibodies to constituents of PMN (e.g., PR3 [PR3-ANCA] or myeloperoxidase [MPO] [MPO-ANCA]) are the serological hallmarks of systemic vasculitis, and PR3-ANCA is strongly associated with WG. PR3 and MPO are abundant in neutrophil extracellular traps (NETs) formed by PMN that undergo nuclear disintegration and decondensation. NETs are web-like structures composed of chromatin bound to positively charged molecules (histones, neutrophil serine proteases). NETs play an important role physiologically and act in antimicrobial defense carried out by PMN.23 NETs have been found in glomerulonephritis of WG both in situ and in the bloodstream.24 Excess formation of NETs and their presentation of a modified PR3 also suggest a way by which dying PMN present in microabscesses and contribute to the necrotic areas in the granulomatous lesion and a subsequent rise of PR3-ANCA.20,25 In addition, a NETs-mediated release of factors such as B-lymphocyte stimulator by PMN could, for instance, promote the activation of B cells.26

Figure 3: Schematic overview focusing on different aspects of T cell involvement in WG.
click for large version
Figure 3: Schematic overview focusing on different aspects of T cell involvement in WG. We postulated that WG occurs as localized disease with granuloma (tosis) that is mediated by a Th1-like immune response in the granulomatous lesion. Generalized disease is characterized by granulomatosis + vasculitis with a Th2-type immune response in the granulomatous lesion. However, newer findings report not only more T helper cell subsets than the ones shown here, but also support the idea of a more fluid T cell phenotypic view, including Th17 cells.35

We have reported that germinal center-like structures containing T and B cells are often found within granulomatous lesions and hypothesized that germinal center-like structures might be an important element of a microenvironment that supports autoantibody-producing plasma cells (see references 21, 27, and 28 for a review of this). Indeed, we showed an accumulation of heavy chain variable region immunglobulin gene mutations in the endonasal mucosa of WG, pointing towards an influence of local autoantigens, such as PR3 on the generation of autoimmunity.29

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsVasculitis Tagged with:Diagnostic Criteriagranulomatosis with polyangiitisPathogenesisTreatmentWegener's Granulomatosis

Related Articles

    Reading Rheum

    April 1, 2008

    Handpicked Reviews of Contemporary Literature

    Figure 2: Renal Biopsy

    The Classification & Diagnosis of Granulomatosis with Polyangiitis

    August 16, 2018

    Based on the classification system developed by the Chapel Hill Consensus Conference, anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis is defined as a necrotizing vasculitis involving small vessels that is associated with myeloperoxidase (MPO) ANCA or proteinase 3 (PR3) ANCA and displays minimal immune deposits. The mechanism behind the pathogenesis of ANCA-associated vasculitis is not fully…

    ACR Winter Rheumatology Symposium: Tips for ANCA Testing

    May 1, 2013

    How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests

    Wegener’s Granulomatosis Treatment Today

    October 1, 2008

    WG has an evolving prognosis and treatment course

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences